|
1
|
Boncheva V, Bonney SA, Brooks SE, Tangney
M, O’Sullivan G, Mirnezami A and Guinn BA: New targets for the
immunotherapy of colon cancer-does reactive disease hold the
answer? Cancer Gene Ther. 20:157–168. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Antonic V, Stojadinovic A, Kester KE,
Weina PJ, Brücher BL, Protic M, Avital I and Izadjoo M:
Significance of infectious agents in colorectal cancer development.
J Cancer. 4:227–240. 2013. View
Article : Google Scholar
|
|
3
|
Van den Eynden GG, Majeed AW, Illemann M,
Vermeulen PB, Bird NC, Høyer-Hansen G, Eefsen RL, Reynolds AR and
Brodt P: The multifaceted role of the microenvironment in liver
metastasis: biology and clinical implications. Cancer Res.
73:2031–2043. 2013.PubMed/NCBI
|
|
4
|
Meylan E and Tschopp J: The RIP kinases:
crucial integrators of cellular stress. Trends Biochem Sci.
30:151–159. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Stanger BZ, Leder P, Lee TH, Kim E and
Seed B: RIP: a novel protein containing a death domain that
interacts with Fas/APO-1 (CD95) in yeast and causes cell death.
Cell. 81:513–523. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ye YC, Wang HJ, Yu L, Tashiro S, Onodera S
and Ikejima T: RIP1-mediated mitochondrial dysfunction and ROS
production contributed to tumor necrosis factor alpha-induced L929
cell necroptosis and autophagy. Int Immunopharmacol. 14:674–682.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Meylan E, Burns K, Hofmann K, Blancheteau
V, Martinon F, Kelliher M and Tschopp J: RIP1 is an essential
mediator of Toll-like receptor 3-induced NF-kappa B activation. Nat
Immunol. 5:503–507. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Park YH, Jeong MS, Park HH and Jang SB:
Formation of the death domain complex between FADD and RIP1
proteins in vitro. Biochim Biophys Acta. 1834:292–300. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lu JV and Walsh CM: Programmed necrosis
and autophagy in immune function. Immunol Rev. 249:205–217. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
O’Donnell MA, Hase H, Legarda D and Ting
AT: NEMO inhibits programmed necrosis in an NFκB-independent manner
by restraining RIP1. PLoS One. 7:e412382012.PubMed/NCBI
|
|
11
|
Kelliher MA, Grimm S, Ishida Y, Kuo F,
Stanger BZ and Leder P: The death domain kinase RIP mediates the
TNF-induced NF-kappaB signal. Immunity. 8:297–303. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bellail AC, Olson JJ, Yang X, Chen ZJ and
Hao C: A20 ubiquitin ligase-mediated polyubiquitination of RIP1
inhibits caspase-8 cleavage and TRAIL-induced apoptosis in
glioblastoma. Cancer Discov. 2:140–155. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Festjens N, Vanden Berghe T, Cornelis S
and Vandenabeele P: RIP1, a kinase on the crossroads of a cell’s
decision to live or die. Cell Death Differ. 14:400–410. 2007.
|
|
14
|
Motavaf M, Safari S and Alavian SM:
Therapeutic potential of RNA interference: a new molecular approach
to antiviral treatment for hepatitis C. J Viral Hepat. 19:757–765.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ghafouri-Fard S and Ghafouri-Fard S: siRNA
and cancer immunotherapy. Immunotherapy. 4:907–917. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tan SY, You HX and Zhou YH: Effect of
silencing RIP1 by specific siRNA on the biological behaviour of
human colon cancer cell line LoVo. Chin J Clinicians (Electronic
Edition). 7:3892–3896. 2013.(In Chinese).
|
|
17
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar
|
|
18
|
US Preventive Services Task Force.
Screening for colorectal cancer: US Preventive Services Task Force
recommendation statement. Ann Intern Med. 149:627–637. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Messick CA, Church J, Casey G and Kalady
MF: Identification of the methylator (serrated) colorectal cancer
phenotype through precursor serrated polyps. Dis Colon Rectum.
52:1535–1541. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xie T, Peng W, Liu Y, Yan C, Maki J,
Degterev A, Yuan J and Shi Y: Structural basis of RIP1 inhibition
by necrostatins. Structure. 21:493–499. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang J, Zhang H, Li J, Rosenberg S, Zhang
EC, Zhou X, Qin F and Farabaugh M: RIP1-mediated regulation of
lymphocyte survival and death responses. Immunol Res. 51:227–236.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Osborn SL, Diehl G, Han SJ, Xue L, Kurd N,
Hsieh K, Cado D, Robey EA and Winoto A: Fas-associated death domain
(FADD) is a negative regulator of T-cell receptor-mediated
necroptosis. Proc Natl Acad Sci USA. 107:13034–13039. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang Y, Xia F, Hermance N, Mabb A,
Simonson S, Morrissey S, Gandhi P, Munson M, Miyamoto S and
Kelliher MA: A cytosolic ATM/NEMO/RIP1 complex recruits TAK1 to
mediate the NF-kappaB and p38 mitogen-activated protein kinase
(MAPK)/MAPK-activated protein 2 responses to DNA damage. Mol Cell
Biol. 31:2774–2786. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kim SS, Ahn CH, Kang MR, Kim YR, Kim HS,
Yoo NJ and Lee SH: Expression of CARD6, an NF-kappaB activator, in
gastric, colorectal and oesophageal cancers. Pathology. 42:50–53.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhao J, Jitkaew S, Cai Z, Choksi S, Li Q,
Luo J and Liu ZG: Mixed lineage kinase domain-like is a key
receptor interacting protein 3 downstream component of TNF-induced
necrosis. Proc Natl Acad Sci USA. 109:5322–5327. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dai S, Jiang L, Wang G, Zhou X, Wei X,
Cheng H, Wu Z and Wei D: HSP70 interacts with TRAF2 and
differentially regulates TNFalpha signalling in human colon cancer
cells. J Cell Mol Med. 14:710–725. 2010.PubMed/NCBI
|
|
27
|
Verbrugge I and Johnstone RW: Regulating
the TRAIL of destruction: how A20 protects glioblastomas from
TRAIL-mediated death. Cancer Discov. 2:112–114. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Handke W, Krause E and Brune W: Live or
let die: manipulation of cellular suicide programs by murine
cytomegalovirus. Med Microbiol Immunol. 201:475–486. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bist P, Leow SC, Phua QH, Shu S, Zhuang Q,
Loh WT, Nguyen TH, Zhou JB, Hooi SC and Lim LH: Annexin-1 interacts
with NEMO and RIP1 to constitutively activate IKK complex and
NF-κB: implication in breast cancer metastasis. Oncogene.
30:3174–3185. 2011.PubMed/NCBI
|
